Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
79 Cards in this Set
- Front
- Back
"Fifth vital sign" |
- Pain
- Must be treated in same manner as other vital signs (inquire about, measure, and treat) |
|
When to treat severe pain
|
At initial onset
|
|
Addition of non-opioids to regimen can ___________ the total opioid dose required
|
Reduce
|
|
Physiological Adaptation
|
Body adapts to chronic opioid use
All patients will become physiologically adapted after repeated exposure |
|
Addiction to opioids
|
Involves a strong desire or compulsion to take the drug despite harm
Is manifested by drug-seeking behavior |
|
Opioid Withdrawal Symptoms
|
Anxiety
Tachycardia Shakiness SOB GI symptoms |
|
Pseudo-addiction
|
D/t poorly treated pain
Patient is often anxious about running out of drug and may have used up the medication too quickly |
|
Tolerance
|
Develops over time
Necessitates a higher dose to produce the same analgesic response |
|
Opioid hyperalgesia
|
Chronic opioid use that can worsen pain sensitivity
Occurs in some patients Switch to different opioid or to other analgesic |
|
Break-through pain
|
Acute pain that occurs despite use of a long-acting or scheduled opioid
|
|
Most important predictor of respiratory depression (usual cause of fatality w/ opioid overdose)
|
Sedation
|
|
Treatment for mild pain
|
NSAIDs
Acetaminophen |
|
Vicodin, Norco, Lortab
|
APAP/Hydrocodone
|
|
Percocet, Endocet
|
APAP/Oxycodone
|
|
Tylenol # 2, 3, 4
|
APAP/codeine
|
|
Ultracet
|
APAP/tramadol
|
|
Ofirmev
|
IV APAP
Used inpatient to enable lower opioid doses Can be used when PO routes are not available |
|
Acetaminophen Dosing for Children
|
10-15 mg/kg Q4-6 hours
Max of 5 doses/day |
|
Acetaminophen dosing
|
Comes in 325 mg, 500 mg, and 650 mg ER (soon will be gone)
325 mg - 2 tabs Q4-6 hours 500 mg - 2 tabs Q6 hours 650 mg - 2 tabs Q8 hours |
|
Acetaminophen Info
|
MOA - inhibits synthesis of prostaglandins in the CNS; peripherally blocks impulse generation
BLACK BOX --- hepatotoxicity SE - hepatotoxicity (alcoholics and hepatitis < 2g/d); severe skin rash (rare) DOC for pain in pregnancy |
|
N-Acetylcysteine
|
Acetadote - antidote for APAP overdose
MOA - restores intracellular glutathione LD - 140 mg/kg PO, then 70 mg/kg Q4hr x 17 doses Odor of rotten eggs; can cause nausea |
|
Acetaminophen Drug Interactions
|
DOC for use w/ warfarin
Avoid/limit alcohol d/t hepatotoxicity |
|
Acetaminophen Counseling
|
Contact Dr if condition worsens, lasts for > 2 days, high fever, or w/ rash, N/V, or blood in the stool
Caution on combo products that contain APAP Avoid/limit alcohol (Men < 2 drinks/d, women <1 drink/d) |
|
NSAID Black Box Warnings
|
- Increased risk of thrombotic events, MI, stroke
- Increased risk of serious GI issues (bleeding, ulceration, and perforation of the stomach or intestines) CONTRA --- peri-operative pain management in the setting of CABG surgery |
|
Aspirin (acetylsalicylic acid)
|
Bayer, Ascriptin, Bufferin, Ecotrin
Salicylic NSAID 325-650 mg dosing CONTRA - pregnancy, hypersensitivity, children < 16 y/o SE - dyspepsia, heartburn, HTN, HI bleeding, severe skin rash (rare) |
|
Ibuprofen
|
Motrin, Advil --- mild-moderate pain, fever, dysmenorrhea
OTC dosing - 200-400 mg Q4-6 hours; limit self treatment to < 10 days (max 1.2 g/d) Rx dosing - 400-800 mg Q6-8 hours (max 3.2 mg/d) |
|
Naproxen
|
Given BID
OTC dosing 250-500 mg Q6-8 hr Rx dosing - 500-1000 mg/d in 2 divided doses Relatively lower cardiac risk than other NSAIDs |
|
Vimovo
|
Naproxen/Esomeprazole
- PPI is used to protect the gut from damage caused by the NSAID |
|
Treximet
|
Sumatriptan/Naproxen 85-500 mg
|
|
Diclofenac
|
Cataflam, Voltaren XR, Flector (patch)
50-75 mg BID Flector patch - AAA BID; remove if bathing/showering; remove for MRI |
|
Arthrotec
|
Misoprostol/Diclofenac 200 mcg/50 mg
CONTRA - women of childbearing potential unless woman is using effective contraceptive measures Misoprostol - increases uterine contractions, causes cramping, diarrhea Used to reduce the risk of GI damage from NSAIDs |
|
Indomethacin
|
Indocin
IR - 25-50 mg CR - 75 mg Used for gout High risk of CNS SEs (avoid in psych conditions), GI toxicity |
|
Piroxicam
|
Feldene
10-20 mg qd Used for inflammatory condition if other NSAIDs do not work; may need agent to protect gut |
|
Ketorolac
|
Toradol
10-20 mg PO; always star w/ IV, IM, or nasal spray before switching to oral **5 day max treatment** Contra - any situation w/ increased bleeding risk SE - GI bleeding and perforation, post-op bleeding, acute renal failure, liver failure, anaphylactic shock |
|
Sulindac
|
Clinoril
NSAID Preferred w/ reduced renal function if NSAID is required |
|
MOA of NSAIDs
|
Inhibit activity of cyclooxygenase enzymes
--- These enzymes catalyze the production of prostaglandins and thromboxane from arachidonic acid ASA - irreversible inhibitor; NSAIDs - reversible NSAIDs Decrease inflammation d/t suppression of PG formation COX-2 --- less bleeding risk, but greater CV risk |
|
Celecoxib
|
Celebrex
50-400 mg Osteoarthritis - 100 BID or 200 qd Rheumatoid arthritis - 100-200 BID HIGHEST COX-2 SELECTIVITY Contra - sulfonamide allergy |
|
Meloxicam
|
Mobic
7.5-15 mg/d COX-2 selective NSAID |
|
Etodolac
|
Lodine
300-500 mg Q6-8 hours COX-2 selective NSAID |
|
Nabumetone
|
Relafen
1-2 g QD (can be divided BID) COX-2 selective NSAID |
|
NSAID Drug Interactions
|
Additive bleeding risk w/ antiplatelets or anticoagulants
Avoid concurrent use of NSAIDs (except 81 mg ASA) Can increase level of lithium and methotrexate (CONTRA w/ lithium) ASA and other ototoxic agents (AMGs, IV loop diuretics, etc) |
|
NSAID Counseling
|
Take w/ food if upset stomach
Increased CV risk Avoid use before elective surgery Can cause ulcers, stomach bleeding Can raise blood pressure Caution/Avoid in hx of MI, heart failure (can cause edema) Limit sun exposure Contra in pregnancy |
|
Opioid MOA
|
Mu receptor agonists
Dose can be increased (no max dose), but there is a limitation to how much pain relief they can offer Rotate high doses w/ other opioids to reduce risk of tolerance |
|
Lidocaine 5% patches
|
Lidoderm - used for postherpetic neuralgia (shingles)
AAA 1-3 patches/day for up to 12 hrs/day SE - minor topical burning, itching, rash |
|
Lidoderm Patient Counseling
|
Can be cut into small sizes before removing backing
DON'T apply more than 3 patches at one time Safely discard patches where children/pets can't get them (fold patch in half w/ sticky side facing in) Don't cover w/ heating pads/electric blankets Don't use on broken/abraded/burned/open skin (increased amount absorbed) |
|
Capsaicin
|
Zostrix, Zostrix HP (0.025%, 0.075%)
Decreases TRPV1-expressive nociceptive nerve endings (decreases substance P levels) AAA TID-QID SE - topical burning, dissipates w/ continued use |
|
Qutenza 8% patch
|
Rx capsaicin patch
Given in the doctor's office only Causes topical burning, requires pre-treatment w/ lidocaine Applied for 1 hours --- lasts for months Indicated for post-herpetic neuralgia (shingles) |
|
Capsaicin Patient Counseling
|
Apply thin layer of cream to AA and rub in gently until fully absorbed
Best results after 2-4 wks; DON'T use prn Wash hands thoroughly after use; if treating hands, leave on for 30 min, then wash hands Will burn eyes, nasal area, mouth, genitals Never cover w/ bandages or heating pad |
|
Topical Methyl Salicylate
|
BenGay, Icy Hot, Precise, SalonPas, TheraGesic
Patches, creams Possibility of 1st-3rd degree burns |
|
Milnacipran
|
Savella
SNRI - Fibromyalgia pain BLACK BOX - Suicidal thinking SE - N/C/HA, dizziness, insomnia, hot flashes Interactions - increases levels of digoxin, increased bleeding risk w/ antiplatelets or anticoags CONTRA - methylene blue, linezolid |
|
Milnacipran Dosing Schedule
|
Day 1 - 12.5 mg QD
Day 2-3 - 12.5 mg BID Day 4-7 - 25 mg BID Then 50 mg BID CrCl < 30 mL/min --- max 25 mg BID |
|
Pregabalin
|
Lyrica - diabetic neuropathic pain, postherpetic neuralgia, fibromyalgia, spinal cord damage
75 mg BID; max 600 mg/d (decrease dose and increase interval if CrCl < 60 mL/min) SE - Dizziness, somnolence, peripheral edema, weight gain, ataxia, diplopia, blurred vision, xerostomia, mild euphoria |
|
Duloxetine
|
Cymbalta - Peripheral neuropathic pain, fibromyalgia, chronic musculoskeletal pain
30-60 mg/d Same SEs are SNRIs SE - nausea, dry mouth, somnolence, fatigue, decreased appetite |
|
Gabapentin
|
Neurontin, Gralise (postherpetic neuralgia), Horizant (postherpetic neuralgia, restless leg syndrome)
300 mg TID; max 3600 mg/d (decrease dose and increase interval if CrCl < 60 mL/min) SE - dizziness, somnolence, ataxia, peripheral edema, weight gain, diplopia, blurred vision, xerostomia ER - take w/ food Used for off-labeled uses |
|
Amitriptyline
|
Elavil
10-50 mg QHS SE - uncommon w/ low doses; QT prolongation w/ overdose, anticholinergic effects |
|
Baclofen
|
Lioresal; antispasmotic w/ analgesic effect
5-20 mg TID-QID prn BLACK BOX - avoid abrupt withdrawal SE - sedation, dizziness, confusion DON'T overdose in elderly |
|
Cyclobenzaprine
|
Flexmid, Amrix ER, Flexeril --- antispasmodic w/ analgesic effect
5-10 mg TID prn; ER - 15-30 mg QD SE - xerostomia Interactions --- don't combine w/ serotonergic agents, may precipitate or exacerbate cardiac arrhythmias |
|
Tizanidine
|
Zanaflex
MOA - central alpha-1 agonist; antispasmodic w/ analgesic effect 2-4 mg Q6-8 hours prn SE - hypotension, dizziness, xerostomia, weakness |
|
Carisoprodol
|
Soma --- exert effect by sedation
C IV 250-350 mg QID prn SE - drowsiness, dependence, withdrawal symptoms ** Poor CYP 2C19 metabolizers will have higher carisoprodol conc. |
|
Metaxalone
|
Skelaxin --- exerts effect by sedation
800 mg TID-QID prn Decreased cognitive/sedative effects Hepatotoxic |
|
Methocarbamol
|
Robaxin --- exert effect by sedation
1500-2000 mg QID prn SE - hypotension (monitor BP) |
|
Muscle Relaxant Interactions
|
- Caution w/ concurrent use of CNS depressants
*Tizanidine - CONTRA w/ cipro and fluvoxamine d/t elevated tizanidine levels |
|
Muscle Relaxant Patient Counseling
|
Will cause drowsiness and fatigue; do not drive while on this medication
Avoid alcohol, sleeping pills, antihistamines, sedatives, pain pills, and tranquilizers except under doctor supervision |
|
Naloxone
|
Opioid antagonist - used for opioid overdose
0.4-2 mg Q2-3 min or IV infusion at 0.4 mg/hr; repeat dosing may be required WIll cause acute withdrawal syndrome (pain, anxiety, tachypnea) in patients physically dependent on opioids |
|
Acute Opioid Overdose S/S
|
Somnolence
Respiratory depression w/ shallow breathing Cold and clammy skin Constricted (pinpoint, miosis) pupils Can lead to coma/death |
|
Buprenorphine
|
Buprenex inj., Butrans patch
Patch - apply to upper outer arm, upper chest, side of chest, upper back Qweekly ---- do not use same site for 3 weeks BLACK BOX (patch) - don't exceed one 20 mcg/hr patch d/t QT prolongation SE - sedation, dizziness, HA, confusion, QT prolongation, respiratory depression Don't expose patch to heat |
|
Suboxone
|
Buprenorphine + naloxone (tabs and SL film)
Used as alternative to methadone Prescribers must had DATA 2000 waiver to prescribe; DEA number will start w/ X |
|
Opioid Drug Interactions
|
- Caution w/ concurrent use of CNS depressants
- Increased risk of hypoxemia (resp. depression) w/ underlying respiratory disease and sleep apnea *Methadone - caution w/ serotonergic agents, agents that worsen cardiac function or increase arrhythmia risk *Meperidine - agents that worsen renal function, elderly, seizure hx, serotonergic agents *Tramadol, tapentadol - agents that lower seizure threshold, serotonergic agents, increased INR w/ warfarin NO ALCOHOL!!! |
|
Opioid Patient Counseling
|
Don't crush, chew, break, or open controlled release forms
NO ALCOHOL!!! Will cause drowsiness/fatigue --- avoid sleeping pills, antihistamines, etc. Take w/ full glass of water; take with food or milk if upset stomach DON'T stop taking suddenly if using >5-7 days Will cause constipation; increase fiber and water intake (stool softener for hard stool; stimulants for scheduled opioid patients) |
|
Tramadol
|
Ultram, Conzip; 50 mg tabs
1-2 tabs Q4 hours prn, max of 400 mg/d (IR) or 300 mg/d (ER) Reduce in renal impairment; ER contraindicated if CrCl < 30 mL/min SE - dizziness, N/C/HA, ataxia, flushing, insomnia, resp. depression CONTRA - seizure hx, head trauma, 2D6 inhibitors Risk of serotonin syndrome in combo w/ serotonergic agents |
|
Ultracet
|
Tramadol/APAP
37.5-325 mg |
|
Tapentadol
|
Nucynta, Nucynta ER
Schedule II IR -- 50-100 mg Q4-6 hours prn; ER -- 50-250 mg BID BLACK BOX - respiratory depression; no alcohol w/ ER form SE - dizziness, drowsiness, nausea --- less GI issues Can cause physiological dependence; risk of serotonin syndrome |
|
Codeine
|
Schedule II; combos are Schedule III; cough syrups are Schedule V
30 mg Q4-6 hours prn; range 15-120 mg BLACK BOX - respiratory depression (children after tonsillectomy, adenoidectomy) High degree of GI side effects -- constipation, nausea |
|
Lorcet, Lortab, Vicodin, Norco
|
Hydrocodone/APAP
Schedule III 2.5, 5, 7.5, 10 mg in combo w/ APAP |
|
Hydrocodone
|
BLACK BOX - respiratory depression, acute or severe bronchial asthma or hypercarbia, suspected of having paralytic ileum
Use lower doses w/ 3A4 inhibitors |
|
Zohydro ER
|
Hydrocodone ER
Schedule II 10 mg Q12 hours, range of 10-50 mg |
|
Meperidine
|
Demerol
Schedule II 50-150 mg Q2-4 hours --- short duration of action DON'T use chronically; in elderly patients Warnings --- renal impairment; elderly at risk for CNS toxicity; risk of serotonin syndrome; metabolite is renally cleared (can cause CNS toxicity) |
|
Methadone
|
Dolophine, Methadose liquid
Schedule II 2.5-10 mg Q8-12 hours; 40 mg is indicated for detox and maintenance tx of opioid-addicted patient BLACK BOX --- QTc interval prolongation; respiratory depression Variable half-life; risk of serotonin syndrome; can decrease testosterone and contribute to sexual dysfunction |
|
Oxymorphone
|
Opana, Opana ER
Schedule II IR - 5-10 mg prn; ER - 5-30 mg BID; take on EMPTY stomach BLACK BOX - alcohol can accelerate release of Opana ER, causing fatal levels; do not break, crush, chew, or dissolve Opana ER tablets Contra - moderate-to-severe liver impairment Decrease dose in elderly, renal or mild liver impairment |